168 related articles for article (PubMed ID: 22538097)
1. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.
Duret C; Wauthoz N; Merlos R; Goole J; Maris C; Roland I; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2012 Aug; 81(3):627-34. PubMed ID: 22538097
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of the DP-4M PennCentury insufflator.
Hoppentocht M; Hoste C; Hagedoorn P; Frijlink HW; de Boer AH
Eur J Pharm Biopharm; 2014 Sep; 88(1):153-9. PubMed ID: 24993307
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
5. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
Depreter F; Amighi K
Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
[TBL] [Abstract][Full Text] [Related]
6. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
Beinborn NA; Du J; Wiederhold NP; Smyth HD; Williams RO
Eur J Pharm Biopharm; 2012 Aug; 81(3):600-8. PubMed ID: 22569473
[TBL] [Abstract][Full Text] [Related]
7. New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats.
Pangeni R; Hassan AAM; Farkas D; Sudarjat H; Longest W; Hindle M; Xu Q
Mol Pharm; 2023 Apr; 20(4):2207-2216. PubMed ID: 36938947
[TBL] [Abstract][Full Text] [Related]
8. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
[TBL] [Abstract][Full Text] [Related]
9. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
[TBL] [Abstract][Full Text] [Related]
10. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
[TBL] [Abstract][Full Text] [Related]
11. The development of a novel dry powder inhaler.
Zhang X; Ma Y; Zhang L; Zhu J; Jin F
Int J Pharm; 2012 Jul; 431(1-2):45-52. PubMed ID: 22543053
[TBL] [Abstract][Full Text] [Related]
12. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
13. A novel aerosol generator for homogenous distribution of powder over the lungs after pulmonary administration to small laboratory animals.
Tonnis WF; Bagerman M; Weij M; Sjollema J; Frijlink HW; Hinrichs WL; de Boer AH
Eur J Pharm Biopharm; 2014 Nov; 88(3):1056-63. PubMed ID: 25460152
[TBL] [Abstract][Full Text] [Related]
14. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
[TBL] [Abstract][Full Text] [Related]
15. Novel dry powder inhalation system based on dispersion of lyophilisates.
Claus S; Schoenbrodt T; Weiler C; Friess W
Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
[TBL] [Abstract][Full Text] [Related]
16. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
17. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
[TBL] [Abstract][Full Text] [Related]
18. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model.
Sinha B; Mukherjee B
Drug Dev Ind Pharm; 2012 Feb; 38(2):171-9. PubMed ID: 21721851
[TBL] [Abstract][Full Text] [Related]
19. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
Littringer EM; Mescher A; Schroettner H; Achelis L; Walzel P; Urbanetz NA
Eur J Pharm Biopharm; 2012 Sep; 82(1):194-204. PubMed ID: 22595133
[TBL] [Abstract][Full Text] [Related]
20. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis.
Young PM; Salama RO; Zhu B; Phillips G; Crapper J; Chan HK; Traini D
Drug Dev Ind Pharm; 2015 May; 41(5):859-65. PubMed ID: 24811055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
